LPL Financial
SMMT icon

LPL Financial’s Summit Therapeutics SMMT Stock Holding History

LPL Financial’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$992K Buy
58,663
+36,402
+164% +$544K ﹤0.01% 4512
2026
Q2 		$324K Buy
+22,261
New +$395K ﹤0.01% 5381
2026
Q1 		– Sell
-13,160
Closed -$230K – 6144
2025
Q4 		$230K Sell
13,160
-9,633
-42% -$181K ﹤0.01% 5361
2025
Q3 		$471K Sell
22,793
-17,212
-43% -$417K ﹤0.01% 4679
2025
Q2 		$851K Buy
40,005
+26,545
+197% +$605K ﹤0.01% 3899
2025
Q1 		$260K Sell
13,460
-2,626
-16% -$52.7K ﹤0.01% 4676
2024
Q4 		$287K Sell
16,086
-591
-4% -$11.5K ﹤0.01% 4564
2024
Q3 		$365K Buy
+16,677
New +$233K ﹤0.01% 4268

Other funds holding SMMT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

LPL Financial's SMMT Position: Q3 2026 in Review

LPL Financial increased its Summit Therapeutics (SMMT) stake by 164% in Q3 2026, buying an estimated $544K and bringing the position to 58,663 shares worth $992K. The position accounts for ﹤0.01% of the portfolio, ranked #4512.

LPL Financial first reported a position in SMMT in Q3 2024 and has held it in 8 quarters since. 211 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • LPL Financial held 58,663 shares of Summit Therapeutics worth $992K as of Q3 2026.
  • LPL Financial bought 36,402 Summit Therapeutics shares in Q3 2026, an estimated $544K.
  • Summit Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #4512 holding.
  • LPL Financial first reported a position in Summit Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 211 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.